FUT4 Rabbit Polyclonal Antibody (PE-Cy5.5)

SKU: orb910738

Description

FUT4 Rabbit Polyclonal Antibody (PE-Cy5.5)

Research Area

CD Markers, Cancer Research, Golgi complex, Cell Biology, Human Lineage-negative, Stem Cell Research, Immunology, Surface Molecules, Molecular Biology, Tumor Biology, Cancer Research, cardiovascular Research

Images & Validation

• Tested Applications: FC, IF
• Dilution Range: Flow-Cyt=1μg/Test, IF=1:100-500
• Reactivity: Human, Mouse
• Predicted Reactivity: Rat

Key Properties

• Antibody Type: Primary Antibody
• Host: Rabbit
• Clonality: Polyclonal
• Isotype: IgG
• Immunogen: KLH conjugated synthetic peptide derived from human FUT4 (251-295/433aa)
• Target: FUT4
• Purification: affinity purified by Protein A
• Conjugation: PE/Cy5.5

Storage & Handling

• Storage: Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
• Buffer/Preservatives: 0.01M TBS (pH7.4) with 1% rAlbumin, 0.02% Proclin300 and 50% Glycerol.
• Concentration: 1mg/ml
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

SSEA-1; 3-FAL; Alpha (1,3) fucosyltransferase; Alpha 13 fucosyltransferase FucT; EC 2.4.1.; ELAM 1 ligand fucosyltransferase; ELAM ligand fucosyltransferase; ELAM1 ligand fucosyltransferase; ELFT; FCT3A; Fuc TIV; Fucosyltransferase 4 alpha 1 3 fucosyltransferase myeloid specific; Fucosyltransferase 4; FucT IV; FUCTIV; Galactoside 3 L fucosyltransferase; Lewis X; LeX; SSEA 1; SSEA1; Stage specific embryonic antigen 1; FUC-TIV.

Quick Database Links

Gene Symbol

FUT4

Yi Sun # 1 2, Luke Maggs # 3, Apekshya Panda 2, Samuel J Wright 2, Angelina M Cicerchia 1, Anne Jenney 4, Matthew D Perricone 4, Caitlin E Mills 4, Giulia Cattaneo 3, Marco Ventin 3, Feng Chen 3, Martin Q Rasmussen 1 2, Alex Miranda 1 2, Or-Yam Revach 1 2, Jacy Fang 1 2, Amina Fu 1 3, Peter J Bowling 3, Tatyana Sharova 3, Aleigha Lawless 3, Peter K Sorger 4, Nabeel Bardeesy 1 2 5, Xinhui Wang 3, Keith T Flaherty 1, Genevieve M Boland 2 3, Arnav Mehta 1 2, Moshe Sade-Feldman 1 2, Cristina R Ferrone 3 6, Russell W Jenkins TBK1 Targeting Is Identified as a Therapeutic Strategy to Enhance CAR T-Cell Efficacy Using Patient-Derived Organotypic Tumor Spheroids Cancer Immunol Res ., (2025)

PubMed: 39785827

Applications

FC

Reactivity

Human